Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Orthofix Medical (OFIX) Other Gross PP&E Adjustments (2016 - 2025)

Orthofix Medical has reported Other Gross PP&E Adjustments over the past 16 years, most recently at $380.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 7.98% year-over-year to $380.1 million, compared with a TTM value of $380.1 million through Dec 2025, up 7.98%, and an annual FY2025 reading of $380.1 million, up 7.98% over the prior year.
  • Other Gross PP&E Adjustments came in at $380.1 million for Q4 2025, up from $352.0 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $380.1 million in Q4 2025 to a low of $221.2 million in Q4 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was $347.7 million (2023), compared with a mean of $308.7 million.
  • The sharpest move saw Other Gross PP&E Adjustments dropped 8.67% in 2022, then soared 57.16% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at $242.2 million in 2021, then fell by 8.67% to $221.2 million in 2022, then soared by 57.16% to $347.7 million in 2023, then increased by 1.25% to $352.0 million in 2024, then grew by 7.98% to $380.1 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Other Gross PP&E Adjustments are $380.1 million (Q4 2025), $352.0 million (Q4 2024), and $347.7 million (Q4 2023).